Background: Contrast-enhanced, computed tomography of the chest (angio-CT) is the preferred modality for evaluating central pulmonary embolism (PE). However, acute PE must be diagnosed quickly, and contraindications to contrast agents, hemodynamic instability preventing transport and radiation exposure may limit its use. Because the mediastinal vessels lie within 5 mm of the trachea and central airways, endobronchial ultrasound (EBUS) imaging may be a feasible alternative to detecting PE. Objectives: To demonstrate the feasibility of detecting PE in the central airways by EBUS. Methods: In a prospective, multicenter pilot study, consecutive patients underwent flexible bronchoscopy with a convex EBUS probe under local anesthesia and moderate sedation within 24 h after angio-CT had documented a central PE. The EBUS images were compared to the CT findings. Results: Among 32 patients (mean age 69 years, 20 men), angio-CT documented 101 PE, of which 97 (96%) were also detected with EBUS. The 4 emboli not detected consisted of 1 in a middle lobe and 3 in a left upper lobe artery. At least 1 embolus was detected with EBUS in every patient, which is sufficient to confirm a diagnosis of central PE. No bronchoscopic complications were observed. Mean procedure time was reduced from 5 min in the first 16 patients to 3 min in the last 16. Conclusions: In this pilot study, EBUS was a feasible and safe approach to detecting central pulmonary emboli. Blinded, comparative trials will be necessary to evaluate its use as a primary tool for diagnosing these emboli.

Keywords:
Pulmonary embolism, Endobronchial ultrasound, Chest computed tomography, Diagnostic test
1.
Pruszczyk P, Torbicki A, Pacho R, Chlebus M, Kuch-Wocial A, Pruszynski B, Gurba H: Non-invasive diagnosis of suspected severe pulmonary embolism: trans-oesophageal vs. spiral CT. Chest 1997;112:722–728.
2.
Perrier A, Roy PM, Sanchez O, Le Gal G, Meyer G, Gourdier AL, Furber A, Revel MP, Howarth N, Davido A, Bounameaux H: Multidetector-row computed tomography in suspected pulmonary embolism. N Engl J Med 2005;352:1760–1768.
3.
Tapson VF: Acute pulmonary embolism. New Engl J Med 2008;358:1037–1052.
4.
Stein PD, Henry JW: Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest 1995;108:978–981.
5.
Fedullo PF, Tapson VF: The evaluation of suspected pulmonary embolism. N Engl J Med 2007;349:1247–1256.
6.
Herth FJ, Eberhardt R, Vilmann P, Krasnik M, Ernst A: Real-time endobronchial ultrasound guided transbronchial needle aspiration for sampling mediastinal lymphnodes. Thorax 2006;61:795–798.
7.
Brenner DJ, Hall EJ: Computed tomography – an increasing source of radiation exposure. N Engl J Med 2007;357:2277–2284.
8.
Stein PD, Fowler SE, Goodman LR, Gottschalk A, Hales CA, Hull RD, Leeper KV Jr, Popovich J Jr, Quinn DA, Sos TA, Sostman HD, Tapson VF, Wakefield TW, Weg JG, Woodard PK; PIOPED II Investigators: Multidetector computed tomography for acute pulmonary embolism. N Engl J Med 2006;354:2317–2327.
9.
Huismann M: Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA 2006;295:172–179.
10.
Resten A, Mausoleo F, Valero M, Musset D: Comparison of doses for pulmonary embolism detection with helical CT and pulmonary angiography. Eur Radiol 2003;13:1515–1521.
11.
Oudkerk M, van Beek EJ, Wielopolski P, van Ooijen PM, Brouwers-Kuyper EM, Bongaerts AH, Berghout A: Comparison of contrast-enhanced magnetic resonance angiography and conventional pulmonary angiography for the diagnosis of pulmonary embolism: a prospective study. Lancet 2002;359:1643–1647.
12.
Cowper SE, Kuo PH, Bucala R: Nephrogenic systemic fibrosis and gadolinium exposure: association and lessons for idiopathic fibrosing disorders. Arthritis Rheum 2007;56:3173–3175.
13.
Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). The PIOPED Investigators. JAMA 1990;263:2753–2759.
14.
Sostman HD, Stein PD, Gottschalk A, Matta F, Hull R, Goodman L: Acute pulmonary embolism: sensitivity and specificity of ventilation-perfusion scintigraphy in PIOPED II study. Radiology 2008;246:941–946.
15.
Schellong SM, Schwarz T, Halbritter K, Beyer J, Siegert G, Oettler W, Schmidt B, Schroeder HE: Complete compression ultrasonography of the leg veins as a single test for the diagnosis of deep vein thrombosis. Thromb Haemost 2003;89:228–234.
16.
Kearon C, Ginsberg JS, Hirsh J: The role of venous ultrasonography in the diagnosis of suspected deep venous thrombosis and pulmonary embolism. Ann Intern Med 1998;129:1044–1049.
17.
Torbicki A, van Beek EJR, Charbonnier B, et al: Task force report: guidelines on diagnosis and management of acute pulmonary embolism. Eur Heart J 2000;21:1301–1336.
18.
Kreit JW: The impact of right ventricular dysfunction on the prognosis and therapy of normotensive patients with pulmonary embolism. Chest 2004;125:1539–1545.
19.
Kucher N, Rossi E, de Rosa M, Goldhaber SZ: Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm Hg or higher. Arch Intern Med 2005;165:1777–1781.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.